What AML Clinical Trial Inequities Do Minority and Ethnic Groups Face?
https://vimeo.com/948960457 Do minority and ethnic groups face acute myeloid leukemia (AML) clinical trial inequities? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses research study results of NCI-designated…
What Are Key Acute Myeloid Leukemia Care Barriers and Solutions?
https://vimeo.com/948960484 What are key barriers and solutions to acute myeloid leukemia (AML) care? Expert Dr. Andrew Hantel from Dana-Farber Cancer Institute and Harvard Medical School discusses factors that create AML care barriers,…
Dr. Andrew Hantel: Why Is It Important for You to Empower Patients?
Dr. Andrew Hantel: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. How does Dr. Andrew Hantel empower his patients in their treatment decisions?…
What Are Myeloma Risk Factors for Veterans and First Responders?
https://vimeo.com/944207734 Veterans and first responders may come into contact with myeloma risk factors, but what are they? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center…
What Are the Advantages of Seeking Care With a Lung Cancer Specialist?
https://vimeo.com/949270857 What are the benefits of seeing a lung cancer specialist? Dr. Thomas Marron discusses the key advantages of specialty care, the value of a second opinion, and options for…
Lung Cancer Treatment Plan Advice | Where Do Clinical Trials Fit In?
https://vimeo.com/949270796 What questions should patients ask about a lung cancer treatment plan? Lung cancer expert Dr. Thomas Marron shares key considerations when choosing therapy and discusses where clinical trials fit…
Expert Perspective | New and Emerging Progress in Lung Cancer Treatment
https://vimeo.com/949270748 What’s the latest in lung cancer research? Dr. Thomas Marron from the Tisch Cancer Institute at Mount Sinai Hospital discusses the advances in targeted therapy and immunotherapy and what…
Antibody Drug Conjugates for Lung Cancer | Advances in Research
https://vimeo.com/949270661 What are antibody drug conjugates, and how are these new agents changing lung cancer care? Lung cancer expert Dr. Thomas Marron defines antibody drug conjugates and explains how they…
How Has Lung Cancer Molecular Testing Evolved?
https://vimeo.com/949270597 What are the latest advances in lung cancer testing? Dr. Thomas Marron discusses the role of molecular testing when choosing therapy and how innovations in technology have revolutionized lung…
Advances in Targeted Lung Cancer Treatments | What You Should Know
Dr. Thomas Marron discusses how these therapies work to treat lung cancer, how the presence of certain mutations can impact care and treatment choices, and the research being done on…
Understanding Oncogene-Driven Lung Cancer: Targeted Therapy Advances and Challenges
https://vimeo.com/948534283 How do the genetic mutations of EGFR and exon 20 impact lung cancer? Expert Dr. Christina Baik from Fred Hutchinson Cancer Center discusses oncogene-driven lung cancer and how it differs from…
Newly Diagnosed Non-Small Cell Lung Cancer | Key Advice for Patients
https://vimeo.com/948533700 What’s key advice for newly diagnosed non-small cell lung cancer (NSCLC) patients? Expert Dr. Christina Baik from Fred Hutchinson Cancer Center discusses genetic testing, essentials to know about your lung cancer,…